Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
The report has estimated 4.74 million deaths for India in 2020 and 2021,
Onshore manufacturing facility is expected to be based in Quebec and produce up to 100 million mRNA respiratory vaccine doses annually
Flagship U.S. facility will include biologic manufacturing and late stage research and clinical development of innovative cancer medicines
Approval based on groundbreaking Phase 3 EXPLORER-HCM trial demonstrating benefit in patients receiving Camzyos versus placebo
The plant is expected to start commercial operations from Q4FY24
Revolution Aspire CT System is manufactured at the company’s new plant launched under the government’s Production Linked Incentives (PLI) Scheme
These bulk orders will contribute to the topline of the company as well as help in improving EBITDA of the company
Revenue from operations up 15% to Rs. 758 crore in fourth quarter
The new lab in the industrial town is SRL’s 4th lab in the state of Jharkhand
Subscribe To Our Newsletter & Stay Updated
